Speaker

Mark Zheng

Venture Partner, VU Venture Partners

Mark Zheng, Venture Partner at VU Venture Partners, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Investor Icebreaker Panel Discussion: When Being Selective, where will Investors Invest? What’s Driving Capital in 2026/27?”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Oncology & Cancer Research

Past appearances

Oncology & Immunology Innovation Partnering & Licensing Summit
9–10 Sept 2026Boston, United States of America
- PanelInvestor Icebreaker Panel Discussion: When Being Selective, where will Investors Invest? What’s Driving Capital in 2026/27?With Kevin White, Vikas Goyal, Taku Fukuzawa, Greco Song
- WorkshopInvestor Introduction Tables: Sit, Connect & Break the Ice: Accelerating ConnectionsWith Kevin White, Vikas Goyal, Taku Fukuzawa, Greco Song

More speakers at Oncology & Immunology Innovation Partnering & Licensing Summit

Carla Bauer
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Akihiro Furukawa
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Adam Gilbert
Science Partner, Flagship Pioneering
Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Jason Kantor
Chief Business Officer, Nurix Therapeutics, Inc.
Nikhil Mutyal
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

See all 54 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mark Zheng, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].